{
    "applicationNumber": "BR 11 2022 000965-8",
    "filingDate": "27/07/2020",
    "grantDate": null,
    "title": "DERIVADO DE ADENOSINA E COMPOSI\u00c7\u00c3O FARMAC\u00caUTICA QUE COMPREENDE O MESMO",
    "nationalPhaseDate": [
        "18/01/2022"
    ],
    "internationalApplication": {
        "pctNumber": "PCT US2020/043713",
        "pctDate": "27/07/2020",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "62/879,414",
            "priorityDate": "27/07/2019"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2664"
        },
        {
            "code": "1.5",
            "description": "Exig\u00eancias Diversas",
            "bulletinNumber ": "2674"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2684"
        }
    ],
    "inventors": [
        "LIANHONG XU",
        "LIANHONG XU"
    ],
    "holders": [
        302545
    ],
    "ipcCodes": [
        "A61P 31/18",
        "C07H 19/16",
        "A61P 31/12",
        "A61K 31/7052",
        "A61K 31/7042",
        "A61K 31/7076"
    ]
}